Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration

Abdalla, 1986, Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients, Clinical Chemistry, 32, 805, 10.1093/clinchem/32.5.805 Adams, 2004, Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus, Journal of Neuroscience, 24, 9441, 10.1523/JNEUROSCI.3290-04.2004 Alelu-Paz, 2008, The mediodorsal thalamic nucleus and schizophrenia, Journal of Psychiatry and Neuroscience, 33, 489 Baker, 2007, Contribution of cystine–glutamate antiporters to the psychotomimetic effects of phencyclidine, Neuropsychopharmacology, 33, 1760, 10.1038/sj.npp.1301532 Baker, 2008, Contribution of cystine–glutamate antiporters to the psychotomimetic effects of phencyclidine, Neuropsychopharmacology, 33, 1760, 10.1038/sj.npp.1301532 Bannai, 1986, Exchange of cystine and glutamate across plasma membrane of human fibroblasts, Journal of Biological Chemistry, 261, 2256, 10.1016/S0021-9258(17)35926-4 Behrens, 2007, Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase, Science, 318, 1645, 10.1126/science.1148045 Carlberg, 1985, Glutathione reductase, Methods in Enzymology, 113, 484, 10.1016/S0076-6879(85)13062-4 Chipana, 2008, Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine, Neurochemistry International, 52, 401, 10.1016/j.neuint.2007.07.016 Choi, 2000, Redox modulation of the NMDA receptor, Cellular and Molecular Life Sciences, 57, 1535, 10.1007/PL00000638 Cosgrove, 1991, Recovery of neuropsychological functions during reduction in use of phencyclidine, Journal of Clinical Psychology, 47, 159, 10.1002/1097-4679(199101)47:1<159::AID-JCLP2270470125>3.0.CO;2-O Danbolt, 2001, Glutamate uptake, Progress in Neurobiology, 65, 1, 10.1016/S0301-0082(00)00067-8 Do, K.Q., Cabungcal, J.H., Frank, A., Steullet, P., Cuenod, M., 2009. Redox dysregulation, neurodevelopment, and schizophrenia. Current Opinion in Neurobiology, 19, 220-230. Do, 2000, Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo, European Journal of Neuroscience, 12, 3721, 10.1046/j.1460-9568.2000.00229.x Ellman, 1959, Tissue sulfhydryl groups, Archives of Biochemistry and Biophysics, 82, 70, 10.1016/0003-9861(59)90090-6 Friston, 1995, Schizophrenia: a disconnection syndrome?, Clinical Neuroscience, 3, 89 Golse, 1977, Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses, La Nouvelle presse médicale, 6, 2449 Góth, 1991, A simple method for determination of serum catalase activity and revision of reference range, Clinica Chimica Acta, 196, 143, 10.1016/0009-8981(91)90067-M Günzler, 1974, An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood, Zeitschrift für klinische Chemie und klinische Biochemie, 12, 444 Gysin, 2007, Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence, Proceedings of the National Academy of Sciences of the United States of America, 104, 16621, 10.1073/pnas.0706778104 Herken, 2001, Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia, Molecular Psychiatry, 6, 66, 10.1038/sj.mp.4000789 Hori, 2000, Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia, Neuropsychopharmacology, 23, 170, 10.1016/S0893-133X(99)00156-6 Ikonomidou, 1999, Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain, Science, 283, 70, 10.1126/science.283.5398.70 James-Walke, 2006, Periadolescent nicotine exposure produces sensitization to reinforcement by diazepam in the rat, Neurotoxicology and Teratology, 29, 31, 10.1016/j.ntt.2006.09.022 Javitt, 1991, Recent advances in the phencyclidine model of schizophrenia, American Journal of Psychiatry, 148, 1301, 10.1176/ajp.148.10.1301 Jones, 2008, Radical-free biology of oxidative stress, American Journal of Physiology: Cell Physiology, 295, C849, 10.1152/ajpcell.00283.2008 Köhr, 1994, NMDA receptor channels: subunit-specific potentiation by reducing agents, Neuron, 12, 1031, 10.1016/0896-6273(94)90311-5 Lipton, 1999, Redox sensitivity of NMDA receptors, Methods in Molecular Biology, 128, 121 Lipton, 2002, Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation, Trends in Neurosciences, 25, 474, 10.1016/S0166-2236(02)02245-2 Lowry, 1951, Protein measurement with the folin phenol reagent, Journal of Biological Chemistry, 193, 265, 10.1016/S0021-9258(19)52451-6 Mahadik, 2001, Oxidative stress and role of antioxidant and [omega]-3 essential fatty acid supplementation in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 463, 10.1016/S0278-5846(00)00181-0 Mahadik, 1998, Elevated plasma lipid peroxides at the onset of nonaffective psychosis, Biological Psychiatry, 43, 674, 10.1016/S0006-3223(97)00282-5 Marek, 2000, Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex, Journal of Pharmacology and Experimental Therapeutics, 292, 76 Matsuzawa, 2008, Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study, PLoS ONE, 3, e1944, 10.1371/journal.pone.0001944 Meister, 1983, Glutathione, Annual Review of Biochemistry, 52, 711, 10.1146/annurev.bi.52.070183.003431 Mićić, 2000, Acetylcholinesterase activity in the mongolian gerbil brain after acute poisoning with aluminum, Journal of Alzheimer's Disease, 2, 1, 10.3233/JAD-2000-2101 Mićić, 2003, Superoxide dismutase activity in the Mongolian gerbil brain after acute poisoning with aluminum, Journal of Alzheimer's Disease, 5, 49, 10.3233/JAD-2003-5107 Ozyurt, 2007, Oxidative stress in prefrontal cortex of rat exposed to MK-801 and protective effects of CAPE, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 832, 10.1016/j.pnpbp.2007.01.029 Paxinos, 2005 Petronijević, 2003, Substrate kinetics of erythrocyte membrane Na, K-ATPase and lipid peroxides in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27, 431, 10.1016/S0278-5846(03)00030-7 Radonjić, 2008, Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration, Physiology & Behavior, 93, 437, 10.1016/j.physbeh.2007.10.003 Raffa, M., Mechri, A., Othman, L.B., Fendri, C., Gaha, L., Kerkeni, A., 2009. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 1178-1183. Reddy, 2003, Reduced plasma antioxidants in first-episode patients with schizophrenia, Schizophrenia Research, 62, 205, 10.1016/S0920-9964(02)00407-3 Reddy, 1991, Enzymes of the antioxidant defense system in chronic schizophrenic patients, Biological Psychiatry, 30, 409, 10.1016/0006-3223(91)90298-Z Reddy, 1996, Free radical pathology in schizophrenia: a review, Prostaglandins, Leukotrienes and Essential Fatty Acids, 55, 33, 10.1016/S0952-3278(96)90143-X Rehncrona, 1980, Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe2+- and ascorbic acid-stimulated lipid peroxidation in vitro, Journal of Neurochemistry, 34, 1630, 10.1111/j.1471-4159.1980.tb11254.x Robinson, 1986, Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Research, 396, 157, 10.1016/0165-0173(86)90002-0 Scheffer, 1995, Plasma lipid peroxidation and HVA in first episode psychosis, Biological Psychiatry, 37, 681, 10.1016/0006-3223(95)94727-E Seelig, 1985, Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney, Methods in Enzymology, 113, 379, 10.1016/S0076-6879(85)13050-8 Shimoda-Matsubayashi, 1996, Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene: a predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease, Biochemical and Biophysical Research Communications, 226, 561, 10.1006/bbrc.1996.1394 Snyder, 1973, Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines, Am J Psychiatry, 130, 61, 10.1176/ajp.130.1.61 Sun, 1978, An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation, Analytical Biochemistry, 90, 81, 10.1016/0003-2697(78)90010-6 Terpstra, 2003, Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra, Magnetic Resonance in Medicine, 50, 19, 10.1002/mrm.10499 Tošić, 2006, Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene, The American Journal of Human Genetics, 79, 586, 10.1086/507566 Tsai, 2002, Glutamatergic mechanisms in schizophrenia, Annual Review of Pharmacology and Toxicology, 42, 165, 10.1146/annurev.pharmtox.42.082701.160735 Tsai, 1998, Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia, American Journal of Psychiatry, 155, 1207, 10.1176/ajp.155.9.1207 Wang, 2001, Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia, Neuroscience, 107, 535, 10.1016/S0306-4522(01)00384-0 Wang, 2003, Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by m40403, a superoxide dismutase mimetic, Journal of Pharmacology and Experimental Therapeutics, 304, 266, 10.1124/jpet.102.041798 Whittaker, 1972, The subcellular fractionation of brain tissue with special reference to the preparation of synaptosomes and their component organelles, Methods of Neurochemistry, 2, 1 Willis, 2007, Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat, NeuroToxicology, 28, 161, 10.1016/j.neuro.2006.10.007 Winter, 2008, Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs, Pharmacology Biochemistry and Behavior, 88, 189, 10.1016/j.pbb.2007.07.007 Winter, 2005, Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram, Pharmacology Biochemistry and Behavior, 81, 694, 10.1016/j.pbb.2005.03.022 Yamada, 1997, Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia, Psychological Medicine, 27, 1223, 10.1017/S0033291797005114 Yao, 2006, Altered glutathione redox state in schizophrenia, Disease Markers, 22, 83, 10.1155/2006/248387 Yao, 2001, Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications, CNS Drugs, 15, 287, 10.2165/00023210-200115040-00004 Zuo, 2007, Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis, Pharmacology Biochemistry and Behavior, 86, 1, 10.1016/j.pbb.2006.05.010